Pharmatest Services

Pharmatest Services (Pharmatest) is a preclinical contract research organization offering translational research services for diseases with unmet clinical needs. We offer full-service research solutions for early drug development. Our focus is on preclinical efficacy models in the fields of cancer and skeletal diseases ranging from in vitro cell culture assays to in vivo models. In addition, we provide model and assay development services for our customers. Pharmatest can help you establish the proof-of-efficacy of your cancer drug candidates with clinically predictive cell culture assays, organotypic 3D models, orthotopic animal models, and disseminated cancer models. Our models of skeletal diseases include...

Preclinical research,drug discovery,drug development,osteoporosis,cancer,osteoarthritis,hormonal action,bone analysis,model development,assay development,efficacy testing,safety testing,radiotherapy,skeletal disease models,oncology cro,clinical biomarker services,pain assesment,metastasis models,bone metastasis,in vitro assays,in vivo models,preclinical efficacy,rare bone disease,osteogenesis imperfecta,and ex vivo analyses

Pharmatest services operates in the Biotechnology research industry.

Pharmatest services's revenue is 11m - 100m

Pharmatest services has 11 - 50 employees.